SPDR S&P Biotech ETF
763 hedge funds and large institutions have $10.2B invested in SPDR S&P Biotech ETF in 2024 Q3 according to their latest regulatory filings, with 88 funds opening new positions, 238 increasing their positions, 269 reducing their positions, and 73 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
763
Holders Change
+8
Holders Change %
+1.06%
% of All Funds
11.04%
Holding in Top 10
21
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+16.67%
% of All Funds
0.3%
New
88
Increased
238
Reduced
269
Closed
73
Calls
$2.8B
Puts
$3.33B
Net Calls
-$526M
Net Calls Change
+$836M
Top Buyers
| 1 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
$912M |
| 2 |
Morgan Stanley
New York
|
$792M |
| 3 |
CI
Clal Insurance
Tel-Aviv,
Israel
|
$141M |
| 4 |
D.E. Shaw & Co
New York
|
$99.1M |
| 5 |
Goldman Sachs
New York
|
$1.26B |
